Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 13,520 | 14,861 | 8,156 | 3,175 | 1,440 |
| Cost of Goods | 4,063 | 5,301 | 1,999 | 606 | 376 |
| Gross Profit | 9,457 | 9,560 | 6,158 | 2,569 | 1,064 |
| Operating Expenses | 13,077 | 16,496 | 11,950 | 8,142 | 6,175 |
| Operating Income | -3,557 | -6,635 | -4,793 | -4,967 | -4,736 |
| Interest Expense | 0 | 0 | 0 | 0 | 195 |
| Other Income | -749 | 3,490 | -539 | 4,753 | 2 |
| Pre-tax Income | -4,306 | -3,145 | -5,332 | -214 | -4,929 |
| Net Income Continuous | -4,306 | -3,145 | -5,332 | -214 | -4,929 |
| Net Income | $-4,306 | $-3,145 | $-5,332 | $-214 | $-4,929 |
| EPS Basic Total Ops | -7.00 | 36.40 | -30.20 | -2.40 | -64.00 |
| EPS Basic Continuous Ops | -7.08 | 36.71 | -30.23 | -2.44 | -64.32 |
| EPS Diluted Total Ops | -7.00 | 36.40 | -30.20 | -2.40 | -64.00 |
| EPS Diluted Continuous Ops | -7.08 | 36.71 | -30.23 | -2.44 | -64.32 |
| EBITDA(a) | $-1,437 | $-4,169 | $-3,171 | $-3,679 | $-3,866 |